- CA$300.17m
- CA$252.95m
- $16.10m
Brief: Profound Medical Corp On March 3, Unit Entered Amended & Restated Credit Agreement With Canadian Imperial Bank Of Commerce
Profound Medical Corp reports results for the quarter ended December 31 - Earnings Summary
Profound Medical Corp expected to post a loss of 35 cents a share - Earnings Preview
Brief: Profound Medical Announces Preliminary Unaudited Fourth Quarter And Full Year 2024 Revenues
Brief: Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares
Brief: Profound Medical and Siemens Healthineers to Offer a Complete Solution for MRI-guided Prostate Therapy
Profound Medical Corp reports results for the quarter ended September 30 - Earnings Summary
Brief: Profound Medical Announces Tulsa Reimbursement Raised To Urology APC Level 7
Brief: Profound Medical Corp Files For Mixed Shelf Of Up To $150 Million – SEC Filing
Brief: Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enables Creation of an Automated TULSA Treatment Plan
Newscasts - Trading at Noon: Wall Street edges higher as new US jobless claims rise again
Profound Medical ADR drops after pricing $20 mln stock offering
Brief: Profound Medical Announces Pricing Of Us$20 Million Public Offering Of Common Shares
Brief: Profound Medical Announces Proposed Public Offering Of Common Shares
Brief: Profound Medical Q3 EPS USD -0.26
Brief: Profound Medical Receives U.S. FDA 510(K) Clearance For Tulsa-Pro® Thermal Boost
Canada Research Roundup: Canadian Natural Resources, Profound Medical, Russel Metals
Brief: Profound Medical Announces First Quarter 2023 Financial Results
Brief: Profound Medical Announces Fourth Quarter And Full Year 2022 Financial Results